Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
life sciences
national blog main
san francisco blog main
2
×
san francisco top stories
abbvie
akouos
allergan
alnylam pharmaceuticals
amag pharmaceuticals
amunix
anirvan ghosh
astrazeneca
biogen
bluerock therapeutics
boulder/denver blog main
boulder/denver top stories
cancer
cancer diagnostics
cancer immunotherapy
cerovene
clinical trials
covid-19
crispr
deals
deerfield management
detroit blog main
detroit top stories
durvalumab
editas medicine
europe blog main
europe top stories
fda
forty seven
fred hutch
freenome
general atlantic
gilead sciences
givosiran
What
announced
2
×
plans
2
×
acquisitions
area
based
bay
bio
biopsy
blood
buildout
cancer
ceo
close
collabs
company
covid
daniel
deal
developing
firm
genomic
gilead
gilead’s
help
introduce
ipo
liquid
lucence
medicine
medicines
month
o’day
roundup
sciences
screening
selection
tests
tow
transformative
treatment
Language
unset
Current search:
plans
×
announced
×
" san francisco blog main "
×
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Liquid Biopsy Firm Lucence Plans Bay Area Buildout With $20M in Tow
